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Abstract: This review focuses on the regulation and modulation of human DNA polymerase δ (Pol δ).
The emphasis is on the mechanisms that regulate the activity and properties of Pol δ in DNA repair
and replication. The areas covered are the degradation of the p12 subunit of Pol δ, which converts
it from a heterotetramer (Pol δ4) to a heterotrimer (Pol δ3), in response to DNA damage and also
during the cell cycle. The biochemical mechanisms that lead to degradation of p12 are reviewed,
as well as the properties of Pol δ4 and Pol δ3 that provide insights into their functions in DNA
replication and repair. The second focus of the review involves the functions of two Pol δ binding
proteins, polymerase delta interaction protein 46 (PDIP46) and polymerase delta interaction protein
38 (PDIP38), both of which are multi-functional proteins. PDIP46 is a novel activator of Pol δ4, and the
impact of this function is discussed in relation to its potential roles in DNA replication. Several new
models for the roles of Pol δ3 and Pol δ4 in leading and lagging strand DNA synthesis that integrate
a role for PDIP46 are presented. PDIP38 has multiple cellular localizations including the mitochondria,
the spliceosomes and the nucleus. It has been implicated in a number of cellular functions, including
the regulation of specialized DNA polymerases, mitosis, the DNA damage response, mouse double
minute 2 homolog (Mdm2) alternative splicing and the regulation of the NADPH oxidase 4 (Nox4).
Keywords: DNA polymerase δ; PDIP46; Poldip3; PDIP38; Poldip2; DNA replication; enzyme
regulation; DNA damage response; p12 subunit; E3 ligases; cell cycle
1. Introduction
Pol δ plays a central role, together with Pol ε and Pol α/primase, as the DNA polymerases
that synthesize the daughter DNA strands at the eukaryotic replication fork. The unraveling of
the biochemistry of the mammalian DNA polymerases has posed significant experimental challenges.
Knowledge of the enzymology of the DNA polymerases is essential to an understanding of their cellular
functions. The biochemical approach is critical as pointed out by Arthur Kornberg in the context of
the discovery and unraveling of the processes of prokaryotic DNA replication [1]. In the following
review, we have focused on the regulation of Pol δ by modification of its subunit structure, and
the modulation of its functions by accessory proteins. For a broader view of regulation of Pol δ and
other polymerases, see [2,3].
1.1. Brief Historical Background
In the early 1970s, three mammalian DNA polymerases were known: Pol α, Pol β and Pol γ [4].
Pol αwas considered to be the replicative polymerase, but did not possess an intrinsic or associated
3′ to 5′ exonuclease activity like the Escherichia coli or T4 bacteriophage DNA polymerases, where
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they function to edit or proofread misincorporated nucleotides [5–7]. Thus, the discovery of a novel
mammalian DNA polymerase with an intrinsic 3′ to 5′ exonuclease activity represented a major
advance. This enzyme, named Pol δ, was studied by a group of investigators at the University of Miami
in Florida, in rabbit bone marrow erythroid cells [8–11], calf thymus [12–14] and human placental
tissues [15–19]. Their approach was the rigorous isolation of the enzyme activities. This initially
resulted in the characterization of a dimeric enzyme, consisting of a catalytic subunit of 125 kDa that
harbored both the polymerase and 3′ to 5′ exonuclease catalytic sites and a p50 subunit. Evidence
that Pol δ was a distinct enzyme from Pol α came from their separation by purification, by their
immunochemical distinction using antibodies against Pol δ [18,20], and by the molecular cloning
of the p125 subunit [21–23]. These studies from the Miami laboratories provided a firm basis for
the identification of Pol δ as a novel proofreading DNA polymerase, and removed concerns that this
new enzyme was merely Pol α contaminated with a cellular exonuclease.
Studies of human placental [17], calf thymus [24] and HeLa Pol δ [25] led to the discovery of
a second human DNA polymerase with an intrinsic 3′ 5′ exonuclease activity, which was named
Pol ε [26,27]. The early history of the study of Pol δ is also notable for the discovery of a factor which
stimulated its activity, and acted to modify synthesis by Pol δ from a distributive to a processive
mode [28]. This protein was identified as proliferating cell nuclear antigen (PCNA), which was
subsequently shown to be a platform for many DNA transactions [29].
These early studies defined mammalian Pol δ as having two subunits, p125 and p50. The third
and fourth accessory subunits were identified as p66/p68 [30,31] and p12 [32] (Table 1). The four
subunits of human Pol δ are encoded by the POLD1, POLD2, POLD3 and POLD4 genes. Pol δ has been
extensively studied in yeast [33]. Saccharomyces cerevisiae (S. cerevisiae) Pol δ consists of the homologs
of the p125, p50 and p68 subunits [34]. Schizosaccharomyces pombe (S. pombe) Pol δ has an additional
fourth subunit, Cdm1 [35–37], which has limited homology to p12 [32]. Molecular cloning of the p125
catalytic subunit of human Pol δ showed that the catalytic cores of the p125 subunits share greater
than 60% similarity with that of S. cerevisiae Pol3 [22,23]. Pol δ and Pol ε are members of the B family
of DNA polymerases that include T4 and Rb69 DNA polymerases.
Table 1. Subunit compositions of Pol δ.
Human p125 p50 p68 p12
Schizosaccharomyces pombe Pol3 Cdc1 Cdc27 Cdm1
Saccharomyces cerevisiae Pol3 Pol31 Pol32 -
1.2. Properties of Human Pol δ4 and Its Subassemblies and the Roles of the p68 and p12 Subunits
The p68/Pol32/Cdc27 subunits of both human and yeasts possess PCNA interacting
protein-boxes (PIP-boxes) at their C-termini [30,34,38]. The p68 subunit has an extended structure,
and is highly charged, suggesting that it is flexible and thus an ideal subunit for mediating PCNA
interaction [39,40]. In S cerevisiae, the Pol32 subunit is not essential, but Cdc27 is required for viability
in S. pombe [39,40]. However, the human Pol δ p125 [41–44] and p12 [45] subunits also interact with
PCNA. The p50 subunit also interacts with PCNA [46], although this interaction is much weaker [47].
Analysis of Pol δ enzymes in which the PIP-boxes of either the p12 [45] or p68 [48] were mutated show
that both are required for full expression of activity.
The human Pol δ heterotetramer (Pol δ4), as well as its subassemblies, have been reconstituted
by their expression in the baculovirus system [49–51]. Pol δ4 has also been expressed in an E. coli
system [52]. The use of the baculovirus expression system allowed for the preparation of highly purified
Pol δ4 and its subassemblies for biochemical studies. Initial difficulties were encountered in obtaining
reproducible behaviors of the subassemblies, including that of the trimer lacking the p12 subunit [50].
This was traced to its instability during the isolation process; additionally, both the p68 and p12 subunits
are more susceptible to proteases than the p125 and p50 subunits [51]. Immunoaffinity chromatography
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was used as a key component of the purification of the Pol δ subassemblies [53]. The preparations
of Pol δ4 and its subassemblies were monitored for the appropriate subunit stoichiometry [51]
because of the possibility of subunit loss during isolation and the fact these subassemblies do exhibit
significant activities.
The activities of Pol δ and its subassemblies were compared by assay using sparsely primed
poly(dA)/oligo(dT) as the substrate in the presence of PCNA [51]. PCNA does not have to be loaded
onto this linear template with the replication factor C (RFC) clamp loader. This “standard” assay
allows reproducible quantitation of Pol δ activities, and specific activities of ca. 20,000 units/mg
were consistently obtained. The relative specific activities and the apparent Kd for PCNA binding
are summarized in Figure 1 [51]. The figure also shows the subunit arrangement of the p125, p50,
p68 and p12 subunits [45]. Notably, the core enzyme and the two trimeric subassemblies all possess
significant activities. The presence of either the p12 or the p68 subunit is able to enhance PCNA
binding and activity of the core enzyme (Table 1). However, as described below, these subassemblies
exhibit defects in assays that require highly processive synthesis.
Genes 2017, 8, 190  3 of 28 
 
appropriate subunit stoichiometry [51] because of the possibility of subunit loss during i olation and 
the fa t these suba semblies do exhibit significant activities.  
The activities of Pol δ and its suba semblies were co pared by a say using sparsely pri ed 
poly(dA)/ li ( )  t  t t  i  t  s ce f  [51].  es t ave to be loaded 
onto this linear te plate ith the replication factor C (RFC) clamp loader. This “stan ar ” assay 
allo s i l  tit ti  of Pol δ activities, and specific activities of ca. 20,00  units/mg were 
consistently obtained. The relative specific activities and the app rent Kd for PCNA bindi g are 
summarized in Figure 1 [5 ]. The figure also shows the subunit arrangement of the p125, p 0, p68 
and p12 sub nits [45]. Notably, the core nzyme and the t o t i i  li  ll possess 
significa t activities.   f it  t    t   s it is able to enhance P  
binding and activity of t e re  ( able 1). r, as escri e  el , these subasse blies 
exhibit defects in assays that require highly proce sive synthesis. 
 
Figure 1. Relative specific activities and proliferating cell nuclear antigen PCNA binding (nM) of Pol 
δ and its subassemblies. Data from [51].  
The second type of assay that has been used is the M13 assay, in which a singly primed M13 
single-stranded DNA (ssDNA) is used as the substrate. PCNA is loaded with RFC, together with 
RPA (single stranded DNA binding protein). This assay monitors synthesis of long strands of DNA 
up to 7 kb on M13 circular DNA and has been used to demonstrate the processivity of Pol δ 
[51,54–56]. However, on long circular ssDNA templates, pausing can be observed where Pol δ4 has 
difficulty synthesizing through regions of secondary structure. In addition, it has been found that 
Pol δ dissociates frequently during these reactions [52]. Thus, while Pol δ exhibits processivity in the 
presence of PCNA, the observed processivity is not continuous (i.e., not due to a single binding 
event) over the entire length of the M13 template. There were marked defects in the abilities of the 
Pol δ subassemblies to synthesize the full-length products, which could be partially compensated for 
by increasing the enzyme concentrations, consistent with a more frequent dissociation from the 
primer template [51].  
2. Alteration in Subunit Composition by the Degradation of the p12 Subunit Is the Key 
Mechanism for the Regulation of Human Pol δ 
There is a surprising paucity of literature on the control of eukaryotic DNA polymerase 
activities by posttranslational modification [2,48,57,58]. The p12 subunit has emerged as a center 
point for regulation of Pol δ [58,59]. The discovery that the p12 subunit is rapidly degraded by 
ubiquitination and proteasomal degradation in response to DNA damage opened a new window on 
the regulation of Pol δ [60]. Later, a similar process was found to take place during the G1/S 
transition under the control of a key regulator of the entry to S-phase, the E3 ubiquitin ligase 
CRL4Cdt2 [61]. The operational outcome of the degradation of p12 is that the Pol δ4 enzyme is 
Figure 1. Relative specific activities and proliferating cell nuclear antigen PCNA binding (nM) of Pol δ
and its subassemblies. Data from [51].
The second type of assay that has been used is the M13 assay, in which a singly primed M13
single-stranded DNA (ssDNA) is used as the substrate. PCNA is loaded with RFC, together with RPA
(single stranded DNA binding protein). This assay monitors synthesis of long strands of DNA up
to 7 kb on M13 circular DNA and has been used to demonstrate the processivity of Pol δ [51,54–56].
However, on long circular ssDNA templates, pausing can be observed where Pol δ4 has difficulty
synthesizing through regions of secondary structure. In addition, it has been found that Pol δ
dissociates frequently during these reactions [52]. Thus, while Pol δ exhibits processivity in the
presence of PCNA, the observed processivity is not continuous (i.e., not due to a single binding event)
over the entire length of the M13 template. There were marked defects in the abilities of the Pol δ
subassemblies to synthesize the full-length products, which could be partially compensated for by
increasing the enzyme concentrations, consistent with a more frequent dissociation from the primer
template [51].
2. Alteration in Subunit Composition by the Degradation of the p12 Subunit Is the Key
echanis for the Regulation of Hu an Pol δ
There is a surprising paucity of literature on the control of eukaryotic DNA polymerase activities
by posttranslational modification [2,48,57,58]. The p12 subunit has emerged as a center point for
regulation of Pol δ [58,59]. The discovery that the p12 subunit is rapidly degraded by ubiquitination
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and proteasomal degradation in response to DNA damage opened a new window on the regulation of
Pol δ [60]. Later, a similar process was found to take place during the G1/S transition under the control
of a key regulator of the entry to S-phase, the E3 ubiquitin ligase CRL4Cdt2 [61]. The operational
outcome of the degradation of p12 is that the Pol δ4 enzyme is converted in vivo to a trimer, Pol δ3,
in synchrony with the S phase (Figure 2). This represents an unusual form of enzyme regulation,
whose significance ultimately rests on understanding the comparative properties of the two forms, and
how these differences operate to facilitate and/or differentiate their functions in DNA repair or DNA
replication. In the following subsections, the mechanisms for the formation of Pol δ3 and the properties
of Pol δ4 and Pol δ3 in DNA repair and replication are reviewed.
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2.1. The Degradation of the p12 Subunit of Pol δ in Response to DNA Damage
Ultraviolet (UV) damage has been extensively used to study cellular responses to DNA
damage. UV treatment of cells triggers global nucleotide excision repair (NER), and activates
translesion synthesis (TLS) to deal with the effects of the bulky lesions that are barriers to replicative
DNA polymerases. UV exposure also triggers checkpoints that result in the inhibition of cellular
DNA synthesis [62] through the activation of Ataxia telangiectasia and Rad3-related (ATR) [63,64].
The intra-S phase checkpoint leads to slowing of progression through the S-phase, and acts by
the inhibition of late firing origins of initiation of replication, and also by slowing the rates of replication
fork progression [65].
We examined the effects of UV treatment of cells on Pol δ by Western blotting of all four of its
subunits to determine if evidence for band-shifts caused by phosphorylation events were detectible.
Instead, this led to the discovery that the p12 subunit was rapidly degraded in response to UV
damage [60]. This study characterized in a rigorous manner the loss of the p12 subunit of Pol δ
in response to genotoxic stress. The significant findings are summarized below:
• p12 is rapidly lost in a variety of cell types, in a UV flux- and time-dependent manner, followed
by a slower recovery over 24 h.
• Treatment with alkylating agents such as methyl methanesulfonate (MMS) or agents inducing
replication stress (hydroxyurea and aphidicolin) also caused p12 degradation.
• The loss of p12 is due to an accelerated rate of proteasomal degradation initiated by
its polyubiquitination.
• Degradation of p12 is dependent on ATR signaling, but not on ATM, as shown by the use of ATR
or ATM depleted cells.
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• The p12 subunit of Pol δ is selectively targeted, and similar changes are not observed for the other
three subunits.
• Loss of the p12 subunit leads to the in vivo conversion of Pol δ4 to the heterotrimer, Pol δ3.
The final observation noted above is of some importance. Prior to these studies, Pol δ4
was considered to be the holoenzyme form, so that the first idea to come to mind was that this
might be a way to disable Pol δ4 activity. However, the Pol δ3 isolated from UV-treated cells by
immunoaffinity chromatography exhibited significant activity. Direct comparisons of Pol δ3 produced
in vivo by UV treatment with recombinant Pol δ3 showed that they had similar properties [51,60]
(see Section 1.2 for comparative properties of Pol δ4 and Pol δ3).
Thus, the question is whether Pol δ3 exhibits advantages over Pol δ4 in DNA repair. The route to
gaining insights into this possibility came from testing their functionalities utilizing highly purified
proteins in specialized assays.
2.2. Pol δ3 Exhibits Altered Behaviors from Pol δ4 in Lesion Bypass and in Extension of Mismatched Primers
that Represent a Gain of Function
In order to probe for advantages for the presence of Pol δ3 in cells subjected to genotoxic agents,
a comparison of its behavior with that of Pol δ4 was made in two contexts. First, replicative polymerases
encounter small lesions that can be bypassed by eukaryotic DNA polymerases in an error prone
manner [66,67]. Second, replicative polymerases encounter lesions that act as severe obstacles to chain
extension: these include abasic sites and thymine-thymine dimers. Model templates with small lesions
were used to study the behavior of Pol δ4 and Pol δ3 [68]; these were O6-MeG (O6-Methylguanine),
which is produced by alkylating agents [66], and 8-oxoG (7,8-dihydro-8-oxoguanine), which
is produced by reactive oxygen species [67]. Templates containing abasic sites and thymine-thymine
dimers were used as examples of lesions that are not readily bypassed. Pol δ3 exhibits a decreased
tendency for bypass synthesis across these templates. Pol δ3 exhibits a higher exonuclease/polymerase
ratio than Pol δ4, suggesting that it was more efficient in proofreading. Further analysis showed that
Pol δ3 is less likely to extend mismatched primers or to misincorporate wrong nucleotides in single
nucleotide incorporation assays. Overall, this study indicated that Pol δ3 exhibited behavior consistent
with it being more discriminatory than Pol δ4, i.e., of having a greater fidelity within the context of these
biochemical assays [68]. The inference drawn is that the p12 subunit exerts an influence on the intrinsic
properties of Pol δ, which could originate from effects on the polymerase or the exonuclease activities,
or both.
The kinetic [69,70] and structural bases [71,72] for the fidelity of replicative polymerases is well
understood. The rate constant for polymerization, kpol, plays a major role in the avoidance of
misincorporation of wrong nucleotides or in mutagenic bypass [69,70]. This is the so-called kinetic
barrier, in which kpol is reduced on encounter with template lesions, the binding of wrong nucleotides,
or the presence of a mismatched primer end. This increases the probability for transfer of the primer
end to the exonuclease site. The second important kinetic constant is kpol-exo, the rate at which
the primer end is translocated from the pol active site to the exonuclease site [73,74]. This transfer rate
is the rate-limiting step for the exonuclease activity in the kinetic scheme [69]. Thus, for a given
polymerase the determination of kpol and kpol-exo provides information on the polymerase and
exonuclease, respectively, while the ratio of kpol-exo to kpol may be regarded as a ratio of editing
to extension, and an index of its proofreading propensity.
Pre-steady state kinetic analysis was used to determine the kinetic constants for Pol δ4 and
Pol δ3 [58,75]. The differences between the two key kinetic constants are summarized in Figure 3,
as the ratio of their changes (Pol δ3/Pol δ4). The removal of p12 leads to a nearly five-fold decrease
in kpol, and a greater than eight-fold increase in kpol–exo, such that the ratio of editing to extension
increased by ca. 40 fold (Figure 3). Both polymerase (kpol) and exonuclease (kpol-exo) are affected. Thus,
by these measures, Pol δ3, compared to Pol δ4, exhibits properties of a polymerase that intrinsically
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proofreads more frequently and should exhibit greater fidelity. These findings are consistent with
the observed behavior of Pol δ3 when tested on lesion containing templates [68].Genes 2017, 8, 190  6 of 28 
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δ3 dissociates from the PCNA/DNA primer-template more readily than Pol δ4 [58,93]. This model
is consistent with the idea that ubiquitination of PCNA and p12 represent related cooperative events
that are involved in TLS at the lesion sites.
The determination of the structure of mono-ubiquitinated PCNA (ub-PCNA) reveals that
the ubiquitins are oriented in a radially extended fashion, below the plane of the PCNA trimer, and
on the opposite face of PCNA where the PIP-box binding pockets are located [93]. Additionally,
the ubiquitins displayed no contacts with PCNA beside the isopeptide linkage, and exhibit
the possibility of significant conformational flexibility. Mono-ubiquitinated PCNA was found to
lead to inhibition of the combined reactions of Pol δ4 and Fen1 (Flap endonuclease 1) activity
in Okazaki fragment processing [93]. This could potentially contribute to the UV-induced inhibition of
DNA synthesis.
2.5. Does the Plasticity of Pol δ Subunit Composition Extend to Other Subunits besides p12?
The demonstration that Pol δ is regulated by modification of its quaternary structure raises
the question of whether the other subassemblies of Pol δ could also be generated in vivo to serve
a functional role. Phenotypic analyses of the deletion of the Pol δ genes should take into account their
potential impact on the Pol δ enzyme. In the case of the p68 subunit, its deletion could potentially
result in the formation of the Pol δ3 trimer consisting of the core + p12 (Figure 1). This trimer has
activity in the standard assay which is comparable to that of Pol δ4. However, deletion of the POLD3
gene is lethal in the animal system. Conditional knockouts of POLD3 in mice have shown that it
is essential for development, and exhibits haploinsufficiency [94]. Deletion of POLD3 in B lymphocytes
led to severe replication defects and genomic instability. The mechanism was traced to a severe loss of
the p125 catalytic subunit, consistent with a loss of stability of the Pol δ complex [94]. It seems unlikely
that a regulated conversion of Pol δ4 to yield the Pol δ3’ trimer lacking p68 occurs in mammalian
cells, as this would coincide during S phase with the degradation of p12, leaving the Pol δ dimer as
the major form. However, it is noted that a temporally restricted reversible loss of p68 outside the S
phase might occur. In contrast to the effects of gene deletion in mice, DT40 chicken lymphocytes cells
in which the POLD3 gene is deleted are viable, and the cells replicate with a moderate S phase delay,
but exhibited increased sensitivity to genotoxic stress [95]. Deletion of the p68 ortholog, Pol32, is not
lethal in S. cerevisiae [34], but deletion of Cdc27 in S. pombe is lethal [38]. Apart from an impact on Pol δ,
loss of the POLD3 gene would also impact Pol ξ, which utilizes the Pol δ p50 and p68 subunits [96,97].
2.6. RNF8 Is Involved in DNA Damage-Induced p12 Degradation
The identification of the E3 ubiquitin ligase(s) that target p12 for degradation is important
in understanding how p12 degradation and the ensuing generation of Pol δ3 is integrated into
the signaling systems that comprise the DNA Damage Response (DDR) and the DNA Damage
Tolerance (DDT) pathways [63,81,85,87]. Two E3 ligases that target p12 for degradation have
been identified: RNF8 [98] and CRL4Cdt2 [61,77]. RNF8 was identified by a classical biochemical
approach [98]. An in vitro assay system was devised for the detection of the polyubiquitination of
GST-p12. Such in vitro assays require the combined actions of an E1 ubiquitin activating enzyme, an E2
ubiquitin conjugating enzyme and an E3 ubiquitin ligase. UbcH5c, which is active with a number of E3
ligases [99] was used as the E2 enzyme, and GST-p12 as the substrate. An E3 ligase fraction was purified
from HeLa cell extracts by conventional chromatographic methods. This preparation was subjected to
proteomic analysis by LC/LC/MS/MS; this yielded three peptides that were identified as sequences
from RNF8. Western blotting of the column fractions confirmed the presence of RNF8, and in vitro
assays of recombinant RNF8 showed that it had a robust activity for the ubiquitination of GST-p12.
Depletion of RNF8 confirmed that the rates of p12 degradation by UV or by alkylation with MNNG
(N-Methyl-N’-Nitro-N-Nitrosoguanidine) were significantly reduced [98].
RNF8 has a major role in orchestrating the ATM regulated DDR through the noncanonical
polyubiquitination of histone H2A [79–81,100]. The discovery that RNF8 mediates the regulation of
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Pol δ is surprising, as this raises the question as to whether RNF8 also plays significant roles in NER
and the DNA damage tolerance pathway that involves activation of translesion synthesis by PCNA
ubiquitination. RNF8 is recruited to DNA damage foci induced by UV [98,101]. RNF8, together
with UbcH5c, efficiently mono-ubiquitinates PCNA in vitro; mono-ubiquitinated PCNA (ub-PCNA)
is further polyubiquitinated via K63 isopeptide linkages by RNF8/UbcH5c and Ubc13/Uev1a [102].
Depletion of RNF8 by shRNA was found to suppress ub-PCNA formation in UV-treated A549
cells [102]. These observations suggest that RNF8 might participate in both modulation of Pol δ
and of TLS by PCNA ubiquitination [59]. The possible regulation of Pol δ and Pol η by RNF8 could be
a means for cross-talk between the ATR and ATM signaling pathways [59]. However, further work
is needed to establish what role RNF8 plays in ub-PCNA formation in vivo.
2.7. Degradation of p12 by CRL4Cdt2
Depletion of RNF8 did not completely block the degradation of p12 in response to UV damage,
indicating that more than one E3 ligase is involved. CRL4Cdt2 was found to target p12 for degradation
in response to UV, and also mediates the degradation of p12 before entry into S phase [59,61].
The CRL4Cdt2 ubiquitin ligase plays a critical role in the prevention of re-replication, as the “master
coordinator of cell cycle progression and genome stability” [103]. CRL4Cdt2 is a member of the
Cullin Ring Ligase family of E3 ubiquitin ligases and targets the licensing factors that are involved
in the assembly of the pre-replicative complex during G1, so that they are removed during the G1/S
transition [104]. The primary targets of CRL4Cdt2 are Cdt1, p21 (p21Waf1/CIP1) and the histone acetylase
Set8. CRL4Cdt2 recognition of its substrates depends on their possession of an extended PIP-box,
termed a PIP-degron. These PIP-degrons have a higher affinity for PCNA than PIP-boxes, and their
degradation also requires that PCNA be loaded onto DNA [105,106]. Studies in Xenopus extracts have
shown Cdt1 destruction is dependent on the initiation of DNA replication as well as Pol α, indicating
that PCNA is loaded onto the primer end [107]. CRL4Cdt2 also targets its substrates for destruction
in response to DNA damage by UV [108,109]. Both p21 [110] and Cdt1 are degraded in response to
UV damage [108,111–114].
The p12 subunit of Pol δ possesses a PIP-degron, and is a substrate for CRL4Cdt2 [61,77]. Mutation
of the PIP-degron of p12 reduces its UV-induced degradation. Depletion of either of the two isoforms
of Cul4 [115] also suppresses UV-induced p12 degradation with similar time courses as for p21 [59,61].
The NEDD8-activating enzyme (NAE) is required for Cullin ligase activity; the NAE inhibitor,
MLN4924 [116], blocks UV and IR degradation of p12 [59,77]. CRL4Cdt2 has also been shown to
be required for the UV-induced inhibition of DNA synthesis; furthermore, replication fork progression
is inhibited and is dependent on p12 degradation [77]. The latter findings provide evidence that
p12 degradation contributes to the elongation checkpoint that is a component of the intra-S phase
checkpoint [65,117].
Analysis of the cell cycle behavior of p12 and its dependence on CRL4Cdt2 were examined
in synchronized cell populations together with that of p21. These studies showed that p12 levels
were reduced during S phase and returned to basal levels during G2/M [59,61]. Depletion of CRL4Cdt2
isoforms reduced the S phase degradation of p12 [59,61]. At the same time as p12 undergoes a decrease
during the S phase, levels of the other subunits of Pol δ remain fairly constant. Thus, the degradation of
p12 by CRL4Cdt2 leads to the formation of Pol δ3 in synchrony with the S phase [59,61]. The regulation
of Pol δ3 is orchestrated by CRL4Cdt2 through common molecular mechanisms by which it controls its
other substrates, and speaks to the significance of Pol δ3 as a participant in DNA replication. The cell
cycle variations in p12, p21 and Cdt1, broadly follow comparable time courses consistent with their
regulation by CRL4Cdt2. This has been demonstrated at the single cell level by laser scanning cytometry,
coupled with analysis of DNA replication by 5-Ethynyl-2’-deoxyuridine (EdU) labeling [118,119].
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2.8. Mechanism and Characteristics of Okazaki Fragment Processing by Pol δ4 and Pol δ3
Discontinuous DNA synthesis at the lagging strand in eukaryotes involves the synthesis of
Okazaki fragments of ca. 200 nucleotides. The process of Okazaki fragment maturation is essentially
one where they are joined to the growing lagging strand. The key elements of this process have been
characterized by biochemical reconstitution and genetic studies [33,120]. In yeast, Pol δ has been
shown to have properties that are conducive to a role in Okazaki fragment processing. One of these
is its propensity to idle at a nick, thereby allowing DNA ligase action [121]. On encounter with a 5′
end of the previous Okazaki fragment, Pol δ will advance several nucleotides because of fraying of
the primer end and strand displacement, creating short flaps. These short flaps are then cleaved by Flap
endonuclease 1 (Fen1) [120,122], so that the primer ends are removed. This process is termed the short
flap pathway, and the products are predominantly mononucleotides and short oligonucleotides of
2–10 nucleotides (nt). However, Fen1 does not cleave longer flaps, and the accumulation of longer flaps
acts as a barrier to Okazaki fragment maturation and is a potential source of genomic instability. While
yeast Pol δ is able to idle at a nick, it does possess a significant ability for strand displacement [123],
so that creation of long flaps can take place. A second pathway, the “long flap pathway”, cleaves
these long flaps via the actions of Pif1 helicase and Dna2 to a length that allows their removal by
Fen1 [120,124]. The final step is ligation of the nick by DNA ligase I [125]. This can be contrasted
to the situation in prokaryotes, where the removal of the primers is performed by a nick translation
mechanism in which Pol I both extends the primer end and excises single nucleotides from the 5′ end
of the prior Okazaki fragment by virtue of its 5′ to 3′ exonuclease activity [126].
The behavior of human Pol δ4 and Pol δ3 in the component and complete reactions of Okazaki
fragment processing were compared in a reconstituted system [59,127]. The key observations were that
Pol δ4 is proficient in strand displacement, and performs Okazaki fragment processing in a manner
similar to that of yeast Pol δ in combination with Fen1. The spectrum of flap sizes ranges from 1 to
8 nt, but is dependent on Fen1 concentration. With increasing Fen1 the product spectrum is shifted to
1–3 nt, with the mononucleotide prevailing. Pol δ3 does not perform strand displacement. With Fen1
and Pol δ3 the primary products are single nucleotides and a smaller amount of di- and trinucleotides.
The rate and nature of product formation distribution is relatively unaffected by Fen1 concentration,
supporting the proposal that mammalian Okazaki processes might involve a PCNA/Pol δ3/Fen1
complex [127], in analogy to that which has been demonstrated in the Archaeal system [128].
The question then arises, why do we need two Pol δ forms for lagging strand synthesis?
The answer may lie in the complex nature of genomic DNA. It is possible that there are template
regions that Pol δ4 is more capable than Pol δ3 of traversing. In this view, we would assign Pol δ3 as
the primary agent for Okazaki fragment synthesis and processing. The preference for the use of Pol δ3
and a nick translation mode of Okazaki fragment processing lies in the avoidance of the generation of
long flaps. Pol δ4 could also be used in Okazaki fragment processing, under circumstances discussed
below (see Section 3.4).
The large number of Okazaki fragments that needs to be generated during synthesis of the human
genome requires that the process be highly efficient, and the tendency of Pol δ to frequently dissociate
is compatible with the need for rapid recycling of Pol δ (see Section 1.2). The properties that Pol δ
displays in Okazaki fragment processing are similar to those needed for gap filling in DNA repair in
terms of the length of DNA synthesis that is required [127]. The role of PCNA may hold more importance
in this context as a platform for coordinating the reactions of Pol δ, Fen1 and DNA ligase I than its role
as a processivity factor. The kinetic constants for Pol δ4 and Pol δ3 [75] provide for an estimate or a
prediction of their processivity, based on the ratio of kpol to koff which can be approximated by kcat [129].
These provide values of 350 and 106 nt for Pol δ4 and Pol δ3 respectively. In contrast, yeast Pol δ is able
to sustain DNA synthesis in a strictly processive manner to at least 5 kb [130].
The findings that yeast Pol δ is adapted for Okazaki fragment maturation have led to extensive
studies that support a division of labor between Pol δ and Pol ε at the replication fork, where Pol δ
is the lagging strand polymerase and Pol ε is the leading strand polymerase. Much of the evidence
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for a division of labor is based on several genetic studies using mutant polymerases that allow
discrimination between leading and lagging strand DNA synthesis (reviewed in [131]). How human
Pol δ fits into this concept must now also take into account the presence of Pol δ4 and Pol δ3,
although their properties suggest that they are more adapted to lagging than leading strand synthesis
(see Sections 3.3 and 3.4 below for further discussion).
A controlled balance between Pol δ4 and Pol δ3 appears to be required in vivo for genomic stability.
Reduced expression of the POLD4 gene has been associated with lung cancer and a poor prognosis for
certain lung cancer patients [132,133]. siRNA suppression of p12 in cultured cells was found to lead to
cell cycle delay, and an elevated frequency of chromosomal aberrations [132,133].
3. Role of the Pol δ Binding Protein PDIP46/Poldip3 in DNA Replication and Repair
There has been a search for accessory or auxiliary proteins that could modulate Pol δ activity since
its initial discovery. Two novel Pol δ interacting proteins of previously unknown functions, PDIP46
(Poldip3) and PDIP38 (Poldip2), were discovered by yeast two hybrid screening with the p50 subunit
of Pol δ as the bait [134]. An independent study identified tumor necrosis factor α and interleukin
6 inducible protein (TNFAIP1) as a Pol δ binding protein (PDIP1/Poldip1) [135]. All three Pol δ
interacting proteins share in common the abilities to bind to the p50 subunit and PCNA. The functions
of Poldip1, PDIP38/Poldip2 and PDIP46/Poldip3 in relation to Pol δ have proven to be enigmatic, and
they appear to be multifunctional proteins.
PDIP46 was re-discovered as S6K1 Aly/REF-like target (SKAR) [136]. SKAR possesses a RRM
(Figure 4) with strong homology to the Aly/REF RNA binding proteins. The latter are involved
in coupling transcription with pre-mRNA splicing and mRNA export [136]. S6K1 (ribosomal protein
S6 kinase-1) lies downstream of the mTOR and PI3K signaling pathways that regulate cell growth and
proliferation through nutrient, energy and mitogenic signals [137,138]. SKAR is a nuclear protein, and
is also present in the nuclear speckles and the EJC (exon junction complex) where it acts to enhance
translational efficiency [139–141]. Activation of S6K1 through the mTOR and PI3K signaling pathways
leads to phosphorylation of PDIP46 at S383/S385. This phosphorylation is required for the binding
of activated (phosphorylated) S6K1 binding to PDIP46 (Figure 4). This leads to their recruitment to
the spliceosomes where S6K1 regulates translational efficiency [136,141]. siRNA depletion of S6K1
leads to smaller cell size [138], and this effect is also produced by siRNA depletion of SKAR and
4EBP1/eIF4E [142]. Thus, PDIP46 serves to translocate activated S6K1 to the spliceosome, subsequent
to the activation of the mTOR pathway. Whether PDIP46, which possesses an Aly/REF type of RNA
binding domain, also independently affects mRNA metabolism is unknown. However, PDIP46 is also
a binding partner of enhancer of rudimentary homolog (ERH) [143]. ERH is a transcriptional regulator
that affects the expression of a number of genes in the cell cycle as well as genes involved in DNA
damage including ATR, and genes involved in DNA replication [144–146].
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3.1. Mapping of the Interaction Sites between PDIP46 and Pol δ /PCNA Reveals that These Are Located
in a Region Separate from Those Involved in S6K1 Binding
The interaction sites of PDIP46 with PCNA and the p50 subunit were mapped to residues 71–125
and that for PCNA between residues 53 and 125 (Figure 4). The PCNA binding of PDIP46 is due to
its possession of a cluster of five APIM motifs [56]. The APIM (AlkB homologue 2 PCNA-Interacting
Motif) is a novel PCNA binding motif that was first identified in the human DNA repair enzyme
oxidative demethylase AlkB Homologue 2 (ABH2) [147]. The APIM consists of five residues with
the consensus sequence [KR]-[FYW]-[LIVA]-[LIVA]-[KR]. Seven other proteins have been shown
to have functional APIM motifs. These include Topo IIα [147], the NER protein XPA [148] and
the F-box helicase FBH1 [149] that is involved in homologous recombination. The APIM motif binds to
the same regions of PCNA as the PIP-box [150]. The separation of the locations of the PCNA/Pol δ
binding regions from the RRM/S6K1 binding domain in the C-terminus (Figure 4) is consistent with
the possibility that PDIP46 is a bi-functional protein whose two functions are harbored in two separate
structural domains [56].
3.2. Evidence that PDIP46 Is Associated with Pol δ In Vivo
There is supportive evidence that PDIP46 interacts with Pol δ in a cellular context. This has been
demonstrated by their co-immunoprecipitation and co-elution during affinity chromatography on
immobilized anti-p125 monoclonal antibody. ChIP analysis with antibody against the p125 subunit
showed that PDIP46 was present together with two components of the mammalian replisome [56].
These are Mcm2, a component of the Cdc45-MCM-GINS (CMG) helicase [151], and Ctf4, which
associates with CMG [152,153]. Thus, the ChIP data supports the idea that PDIP46 is associated with
chromatin at or near the replisome.
3.3. PDIP46 Is a Potent Activator of Pol δ
All PCNA binding proteins possess the ability to compete with Pol δ for PCNA, and therefore
can inhibit Pol δ in activity assays at sufficiently high concentrations. This was found to be the case
for PDIP46 [56] and PDIP38 [154], when assayed using poly(dA)/oligo(dT) as the substrate. More
recently, the effects of PDIP46 on Pol δ activity were examined in the M13 assays in which PCNA
is pre-loaded onto the primer end with RFC. This assay is more reflective of DNA synthesis in vivo than
the standard assay using poly(A)/oligo(dT) as the substrate (see Section 1.2). PDIP46 was revealed to
be a remarkably potent activator (ca. 10 fold) of Pol δ4 in the synthesis of the 7 kb M13 DNA, with
an apparent Kd of ca. 34 nM [56]. The mechanisms for this activation could be due to several causes.
These include an increase in processivity, possibly because PDIP46 may stabilize Pol δ binding to
PCNA by a bridging interaction, as well as by a direct activation that involves alteration of the kinetic
properties of Pol δ4.
The effects of PDIP46 were examined on model oligonucleotide templates [127] in assays that
examined primer extension and strand displacement in order to gain insights into its mechanism(s)
of action [56]. In the absence of PCNA, Pol δ4 behaves in a distributive fashion, and PDIP46 clearly
stimulates this activity. These results demonstrate that PDIP46 exerts a direct effect on Pol δ4.
In the presence of PCNA, the reactions are much faster but it was nevertheless observed that Pol δ4
activity is stimulated. Pol δ3 activity was much less affected than Pol δ4 activity. PDIP46 also stimulated
the strand displacement activity of Pol δ4 using model templates with a blocking oligonucleotide, both
in the absence and presence of PCNA. Little or no effects were observed on Pol δ3, which does not
exhibit strand displacement activity [127].
Next, the effects of PDIP46 on an oligonucleotide substrate with a hairpin/stem-loop (16-nt stem,
8-nt loop) were examined. PDIP46 stimulated Pol δ4 synthesis through the stem-loop by ca. four-fold.
While these effects are smaller than those observed with the M13 template, they explain the greatly
increased rate of accumulation of full-length products by Pol δ4 on the M13 template in the presence
of PDIP46. The M13 template may have many regions of secondary structures. Thus, there would be
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a cumulative effect on overall rates of Pol δ4 synthesis in the presence of PDIP46 [56]. PDIP46 could
act by stabilization of the Pol δ4/PCNA/DNA complex by a bridging interaction (Figure 5), as well as
by a direct activation that involves alteration of the kinetic properties of Pol δ4. The effects of PDIP46
on Pol δ4 are highly relevant in the context of chromosomal replication (Section 3.4.2 below).Genes 2017, 8, 190  12 of 28 
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These studies also highlight the connection between strand displacement and the ability of Pol δ
to synthesize through a hairpin structure. Once Pol δ encounters the hairpin, further synthesis through
the stem portion of the hairpin is analogous to the process of strand displacement [56]. Thus, it is not
surprising that Pol δ3 exhibits minimal activity with the hairpin substrate as it does not perform strand
displacement activity.
Mutations of PDIP46 in which all of the APIM motifs are mutated abolished the effects of PDIP46
on Pol δ4, validating the assignment of PCNA binding to this region. Deletion of the RRM has no effect
on the activation of Pol δ4 by PDIP46, so that PDIP46 appears to have two independent functional
domains [56].
These studies are the first to document the effects of PDIP46 on Pol δ4, and obviously raise many
more questions regarding its mechanism of action. In particular, kinetic studies are needed to establish
whether PDIP46 has any effect on the intrinsic catalytic properties of Pol δ4. Such effects could also
involve alterations in fidelity. In addition, characterization of the range of complexity of secondary
structures in which PDIP46 can act to facilitate Pol δ4 bypass synthesis is important in understanding
the extent to which its functions could facilitate Pol δ4 bypass synthesis.
3.4. Future Horizons: Accommodating Two Forms of Pol δ and PDIP46 at the Replication Fork
Current models for the respective roles of Pol δ and Pol δ at the replication fork are based on
both biochemical and genetic approaches in yeast. Several studies [155–157] using error-prone Pol
δ and Pol ε support a model where Pol δ and Pol ε function mainly as lagging and leading strand
polymerases, respectively (reviewed in [131]). By contrast, it has been argued that genetic approaches
also support a model where Pol δ has a major role on both forks [158]. In the case of human DNA
replication, the differences in subunit structure and properties between yeast Pol δ and human Pol δ
have to be taken into account, in particular the existence of two forms of human Pol δ as well as of
PDIP46, which selectively acts on Pol δ4. In the following sections we propose models for their roles
in lagging and leading strands.
. . . l f l , l I i i t t is
i i l and reconstitution studies have provided strong arguments for an dapt tion of P l
δ for Okaza i fr gment synthesis and processing [59,127]. In the human system, we have two forms of
Pol δ; how do t ese fit into our current views of the replication fork? While bot Pol δ3 and Pol δ4
are capabl of Okazaki fragment processi g in vitro, Pol δ3 exhibits the more desirable characteri tics of
acting th ough a nick translation mode that voids the gen ration of long flaps [59,127]. The model we
propose is that they are used interchangeably during Okazaki fragment s nthesis. This model is based
Genes 2017, 8, 190 13 of 30
on studies reviewed above in Section 2.8. In this model (Figure 6) Pol δ3 is the default lagging strand
polymerase. When regions of secondary structure which act as barriers to Pol δ3 are encountered [56],
Pol δ4 is switched with Pol δ3, together with PDIP46 (Figure 6).Genes 2017, 8, 190  13 of 28 
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structure (red) that pose impediments to Pol δ3 leads to dissociation and triggers a polymerase switch
to Pol δ4/PDIP46.
There are regions of varying template complexity in chromatin that include simple hairpins,
microsatellite regions [159] that contain CFS (common fragile sites), and trinucleotide repeats [160].
These pose potential barriers to the replicative polymerases. There has been a broadening view of
polymerase usage during normal DNA replication, e.g., the utilization of translesion polymerases,
notably Pol κ [161,162] and Pol η in chromosomal DNA replication to augment the functions of
replicative polymerases [88,163–165]. Future characterization of the range of complexity of secondary
structures for which PDIP46 may act to facilitate Pol δ4 bypass synthesis is important to understanding
its functions.
3.4.2. Roles of Pol δ4 and PDIP46 in Leading Strand Synthesis
It is generally accepted that a leading strand polymerase should have high processivity. The loss
of Pol ε function in S. cerevisiae is nonlethal, indicating that yeast Pol δ can act at both leading and
lagging strands [34]. As previously noted, Pol δ3 appears to be much less processive than Pol δ4, so that
it is an unlikely candidate for a role in leading strand synthesis (Sections 1.2 and 2.8). Pol δ4 has been
shown to be less processive than Pol ε [166], so that it might be considered also to be a poor candidate
for leading strand DNA synthesis. However, PDIP46 could augment Pol δ4 function in leading strand
synthesis, in analogy to its effects in the M13 assay that reveal a gain in synthesis rate of about an order
of magnitude [56]. Thus, PDIP46 could function as an accessory protein to provide for Pol δ4 with
the required speed and processivity in leading strand synthesis.
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In addition to a general role as a leading strand polymerase, Pol δ4/PDIP46 could act in
an analogous way as proposed above (Figure 6) in lagging strand synthesis. We propose that Pol εmay
stall at regions of secondary structure, and then is switched for Pol δ4/PDIP46 (Figure 7). The ability
of Pol ε to bypass complex template DNA regions has not been extensively studied. However, Pol ε
exhibits only minimal strand displacement activity, like Pol δ3, and has been shown to be unable
to perform strand displacement [167]. Thus, it might be predicted that Pol ε, like Pol δ3 [56], could
potentially stall at regions of template secondary structures. This model, like that for the lagging
strand, views Pol δ4 (with PDIP46) as functioning as a specialized polymerase to deal with regions of
secondary structure that stall Pol ε.
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Figure 7. Pol δ4/PDIP46 in leading strand synthesis. Regions of secondary structure that pose
impediments to Pol ε (red) lead to disengagement of the catalytic domain of Pol ε. This triggers
a polymerase switch to Pol δ4/PDIP46.
The model shown in Figure 7 incorporates recent structural and functional studies of the yeast
replisome from the Diffley laboratory [168–171]. These studies show that the catalytic domain of Pol ε
is flexibly attached to its non-catalytic domain (which is engaged in complex with the CMG helicase).
The catalytic domain adopts two conformations: it is proposed that in one conformation the catalytic
domain is actively engaged with the DNA and in the other one it is disengaged [168,169]. In the context
of the human replisome, we envisage that encounter with replication blocks stalls Pol ε, leading to
the disengagement of the catalytic domain, followed by a switch to Pol δ4/PDIP46 which performs
the bypass synthesis (Figure 7). When Pol δ4/PDIP46 encounters the CMG helicase, they dissociate
and the Pol ε catalytic subunit re-engages the primer terminus.
The concept that the Pol ε catalytic domain can disengage from the DNA while remaining
an integral part of the CMG-helicase leads to a paradigm shift in our thinking of the replisome [168,169].
Thus, where previously disengagement of Pol ε would require a physical uncoupling, this is no longer
the case. It was proposed that Pol ε can disengage in response to replication stress, a situation that
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entertains the possibility of polymerase switching [168,169]. This is the situation where Pol δ4/PDIP46
could come into play in the model shown in Figure 7.
The studies of the yeast replisome have in fact produced evidence for a switch between Pol δ and
Pol ε, and a mechanism for dealing with uncoupling events. Reconstitution of the initiation of DNA
synthesis supports a model where Pol α forms the primer; this is extended by Pol δwhich then “catches
up” with the replisome to hand off the 3′ end of the leading strand to Pol ε in the advancing and
uncoupled CMG-Pol ε replisome [168,169]. This is essentially a relay of polymerase handoffs where
Pol δ has the anchor role of bringing the growing primer terminus to the CMG-Pol ε. This function of
Pol δ in the yeast replisome provides a mechanism to deal with uncoupling events in a more general
context, as during replication stress [168,169]. In a sense, the view of Pol ε being able to disengage
from the primer end without dissociating from the CMG helicase allows it to have its cake and eat it.
Other studies have also shown that Pol δ dissociates once it encounters the CMG-helicase by a collision
release mechanism; this was taken as a means of selection against Pol δ at the leading strand [172,173].
However, it is noted that this would be dependent on the frequency of disengagement of Pol ε.
Once the possibility of switching of Pol δ and Pol ε is admitted, arguments against the participation
of Pol δ in leading strand synthesis based on our previous understanding of the leading strand
replisome as a tightly complexed structure are weakened. Polymerase switching involving Pol
ε suggests a far more dynamic replisome. Recent kinetic studies have indicated that human Pol
δ dissociates much more frequently than was previously thought [174]. The bacterial replisome
is the prototype of a fixed structural assembly of both leading and lagging strand polymerases with
the clamp loader. However, recent studies indicate that there is a frequent exchange of the bacterial
polymerase during replication [175]. In the case of Pol ε, a similar situation could exist in terms of
disengagement, such that uncoupling might be more frequent than expected even in the absence of
replication stress.
These ideas have significant bearing on the participation of Pol δ4 in leading strand synthesis.
There are no comparable studies that bear on the distribution of labor between Pol δ and Pol ε for
the replication of the far larger and more complex genome in human cells. However, it is noted that
replication of the SV40 genome in reconstituted systems can be achieved with Pol α and Pol δ [176,177].
One study using cross-linking and immunoprecipitation approaches, as well as immuno-electron
microscopy, has provided evidence that Pol δ and Pol ε could be functioning independently in early
and late S phase in the human system [178]. Taking into account recent views on the interplay between
Pol δ and Pol ε during leading strand synthesis in yeast discussed above, it would appear that Pol δ
may participate more extensively in leading strand synthesis than previously recognized.
There is a broader significance to the discovery that the catalytic domain of Pol ε is able to
“switch” away from the DNA. It was proposed that Pol ε could also disengage from the DNA during
replication stress [168,169]. Replication stress, broadly defined as encounter with replication barriers
due to template lesions or complex DNA structures might be addressed by similar mechanisms to
that which are well established in relation to Pol δ [88,179,180] and are based on the switching of
specialized polymerases such as the TLS polymerases. The ability of Pol ε to disengage could also
be involved in replication restart mechanisms that involve re-priming by PrimPol [181]. In the case
of re-priming, the ability of Pol ε to disengage could also open the possibility of Pol α being able to
re-prime, recapitulating the process that occurs during initiation [168,169]. These possibilities point
to a convergence and a more unified view of mechanisms that deal with replication stress at both
the leading and lagging strands of the replication fork.
There is still much to learn about the functions of PDIP46 in DNA replication. In addition to
further biochemical analyses of the mechanisms by which PDIP46 affects Pol δ4, are questions as
to whether PDIP46 functions are regulated by the mTOR pathway or by DNA damage signaling
pathways. The functions of PDIP46 as SKAR indicates that it is a bifunctional protein, pointing
to a need for structural studies, as well as careful dissection of the two functions, to allow design
of appropriate mutations that selectively target its effects on Pol δ. The proposed roles of PDIP46
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in DNA replication would be expected to yield phenotypes in a cellular context when its functions
are disabled that reflect disturbances in DNA replication and genomic stability. Recent studies of
genetic alterations in cells derived from high-risk neuroblastoma tissues have identified a group of
genes whose alterations in copy number resulted in high tumorigenic capacity. The PDIP46 gene
(POLDIP3) was one of six genes whose lowered expression was correlated with decreased overall and
relapse free survival in a cohort of 88 patients [182]. Along with this, immunohistochemical tissue
staining reveals a pattern of lowered expression in over 20 of the most common cancers (Human
Protein Atlas, [183]). The catalogue of somatic mutations in cancer (COSMIC) database also showed
that significant up- or down-regulation of POLDIP3 as being associated with various cancers as
well as a number of mutations [184]. This provides some evidence that PDIP46 function is involved
in maintenance of genomic stability.
4. PDIP38/Poldip2: A Multi-Faceted Protein
Recombinant mature PDIP38 at high concentrations (micromolar) inhibit Pol δ activity, an effect
likely due to competition for PCNA that is unlikely to be physiologically relevant [154]. Thus despite
its binding to Pol δ, the effects of PDIP38 on Pol δ, if any, are as yet not well defined. Studies reviewed
below implicate PDIP38 in a number of cellular processes that are diverse, and further complicated by
its localization to multiple subcellular organelles and structures, as well as its association with multiple
protein partners including a transmembrane enzyme.
4.1. PDIP38 Is a Mitochondrial Protein with Multiple Subcellular Localizations
Analysis of the subcellular localization of PDIP38 revealed that it is primarily a mitochondrial
protein. PDIP38 possesses a mitochondrial targeting site located in the N-terminal 30 amino
acid residues, and cleavage sites [185] for mitochondrial processing peptidase and mitochondrial
intermediate peptidase [154]. The N-terminal 50 residues are efficiently removed to yield a 38 kDa
protein rather than the expected 42 kDa precursor. Cell fractionation experiments indicated that the
bulk of the PDIP38 in cells was in a mitochondrial pellet, and resistant to proteinase K digestion
until the membranes were solubilized with Triton X-100; a smaller amount was present in the nuclear
fraction. Immunofluorescence studies of endogenous PDIP38 as well as of ectopically expressed
C-terminally-tagged EGFP constructs showed that they are localized to the mitochondria [154]. Similar
fractionation and immunofluorescence studies in two other studies confirmed these findings with
the further indication that PDIP38 is present in the mitochondria matrix [186,187]. PDIP38 was found
to associate with mitochondrial single stranded binding protein (mt SSB) and with the mitochondrial
DNA nucleoid/mitochromosome [186,187]. The functions of PDIP38 in mitochondria are still unclear;
in addition to potential effects on mitochondrial DNA replication, its depletion affects mitochondrial
morphology [187], raising a question of whether the effects of its depletion also impacts mitochondrial
energy metabolism.
There are conflicting reports on the subcellular localization of PDIP38. PDIP38 was found to be
an interacting protein for CEACAM1, a cell adhesion receptor [188]. Analysis of its subcellular
localization using peptide directed antibodies showed that the bulk of the PDIP38 is present
in the cytoplasm, but does not co-localize with mitochondrial markers, a result contradictory to
the studies described above. The basis of this difference regarding mitochondrial localization from
those reported above [154] are unknown, although this could be due to differences in the antibodies
used or the fixing of the cells. However, these studies did show significant evidence for PDIP38
in the nuclei. PDIP38 was dynamically localized to the cell surface membranes and the nuclei under
influence of CEACAM1 [188]. Further analysis showed that PDIP38 is localized to the mitotic spindle.
siRNA depletion of PDIP38 or microinjection of PDIP38 antibodies was associated with the appearance
of aberrant spindle formation, chromosome segregation, as well as multinucleate cells [189].
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4.2. Interaction of PDIP38/Poldip2 with Pol η and Other TLS Polymerases: Involvement of PDIP38 in
the DNA Damage Tolerance Pathway
PDIP38 was found to interact directly with Pol η by a yeast two-hybrid screen with Pol η as
the bait. Depletion of Pol η, PDIP38, or both, led to similar degrees of increased sensitivity to UV
in cell survival assays. This suggested that PDIP38 plays an integral role in Pol η function [190].
The molecular mechanisms of the connections between PDIP38 and Pol η remain to be elucidated, but
it has been suggested that PDIP38 might be a mediator in the switching process between Pol δ and
Pol η [190]. In this context, PDIP38 might act to facilitate the recruitment of Pol η to Pol δ stalled at
UV lesions. PDIP38 was also found to bind to the specialized polymerases Rev1 and Pol ξ (through
interaction with the Rev7 subunit) [190]. These findings indicate that PDIP38 might be involved
in the functions of other specialized DNA polymerases. The functional effects of PDIP38 on Rev1 and
Pol ξ have not been reported.
Analysis of the effects of PDIP38 on five different DNA polymerases (Pols δ, η, ι, λ and β) showed
that only the activities of Pol δ, Pol η and Pol λwere affected, consistent with the finding that Pol λ also
physically interacts with PDIP38 [191]. PDIP38 (as the full-length protein) stimulated the processivity
and catalytic activities of Pol η and Pol λ at low nanomolar concentrations on oligonucleotide templates
containing lesions that included 8-oxoG, abasic sites and thymine-thymine dimers [191]. Additionally,
the error-free bypass of 8-oxoG was increased, and a stimulatory effect on Pol δ was also found.
Pol λ [192–194] participates in base excision repair of oxidative damage of guanine bases, as well as
in a form of nonhomologous end joining repair of DSBs [193,195–197]. It was also demonstrated that
depletion of PDIP38 led to an increase in the sensitivity of cultured cells to oxidizing agents [191].
Recently, a sixth polymerase was added to the list of PDIP38 binding proteins, this being PrimPol [198].
PrimPol is a member of the archaeo-eukaryotic primase (AEP) superfamily and exhibits primase,
polymerase as well as translesion polymerase activities, and has emerged as having the ability to
reprime DNA replication at sites of replication stress [181]. The effects of PDIP38 on PrimPol mirror
those found for Pol η and Pol λ, viz., activation, increased processivity and fidelity for bypass of
8-oxoG. Depletion of either PDIP38 or PrimPol (or both) gave rise to replication defects (decrease
in replication fork rates) in response to UV damage, suggesting that they are linked in the same
pathway in vivo [198].
That PDIP38 is capable of interactions with a diverse group of polymerases raises interesting
questions as to how this is achieved. Two similar short amino-acid sequences that are involved
in PDIP38 binding were identified in Pol η [190] and in PrimPol [198]. An N-terminal sequence within
the mitochondrial targeting sequence of PDIP38 was found to be a binding region for PrimPol. Full
length PDIP38, but not the processed form, was able to activate PrimPol and Pol η [198]. These findings
raise the question of whether levels of the unprocessed form in the nuclei would be sufficient to achieve
functional concentrations in vivo, as most of the cellular PDIP38 is in the processed form [154].
The broad versatility of PDIP38 in the regulation of these polymerases, all of which are involved
in the relief of replication stress, makes the elucidation of its structure and the location of its interaction
sites an important goal. Furthermore, the apparently wide reach of PDIP38 in modulating activities of
polymerases involved in translesion synthesis and relief of replicative stress indicates that it is likely
to be under the control of the DNA damage tolerance regulatory pathways, notably those under
the apical ATR kinase.
4.3. PDIP38 Responds to Genotoxic and Transcriptional Stress by Translocation to the Spliceosomes/Nuclear
Speckles and Is Involved in Regulation of the Alternative Splicing of Mdm2
The potential involvement of PDIP38 in Pol η function suggests that it should be recruited to
UV damage foci [190]. Using the technique of UV exposure through UV-opaque polycarbonate filters
with 5 or 10 µm pores to create local areas of irradiation [84], it was observed that PDIP38 was not
recruited to these DNA damage foci, in contrast to Pol η and PCNA [199]. This finding does not negate
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the proposal that PDIP38 is involved in Pol η recruitment [190], since the mechanism is unknown and
might involve a transient association of PDIP38 to DNA damage sites.
Examination of the nuclear localization of PDIP38 showed that it was nevertheless recruited to
nuclear foci in response to UV. These nuclear foci were identified as spliceosomes (nuclear speckles),
which are associated with transcription and mRNA splicing processes [200]. Treatment with UV
increased the number of cells with visible PDIP38 foci, as well as the number of foci per cell. Thus,
the translocation of PDIP38 to the spliceosomes is a novel DNA damage response [199]. In addition to
genotoxic stress, transcriptional stress induced by α-amanitin also led to translocation of PDIP38 to
the nuclear speckles [199]. Interestingly, the human DNA glycosylase hOGG1 is also translocated to
the nuclear speckles under the influence of UVA [201].
The translocation of PDIP38 in response to UV-damage raises the question of its functions
in the spliceosomes/nuclear speckles, which are associated with transcription and mRNA splicing.
There are a number of genes whose alternative splicing is altered under genotoxic stress [202,203].
One of the more extensively studied of these genes is mouse double minute 2 (MDM2) [202,204].
Mdm2 is an E3 ubiquitin ligase that is a negative regulator of p53 [202,205]. Various genotoxic agents,
e.g., UV, camptothecin, doxorubicin and cisplatin, lead to skipping of as many as eight exons, resulting
in disruption of Mdm2 function and of p53 regulation [205]. Alternative spliced variants of Mdm2 also
can exhibit growth regulatory properties independent of p53 and induce tumorigenesis [206–209].
Analysis of the UV induced Mdm2 splice variants in A549 cells showed that this was dependent
on PDIP38, as their levels were suppressed in PDIP38 depleted cells [199]. While the extent
and mechanisms that underlie the basis for the requirement for PDIP38 in Mdm2 alternative
splicing are unknown, it may be another example of the interplay or crosstalk between DNA
damage/repair processes and RNA transcription/splicing in the maintenance of genomic stability and
cell survival [203,210,211]. This crosstalk has largely focused on RNA binding proteins, but also on
the involvement of DNA damage response proteins in regulating splicing factors [210]. The effects of
PDIP38 in modulating the splicing of Mdm2, a key regulator of p53, falls into this category, and may
represent one of its important functions.
4.4. PDIP38 Binds to p22phox and Regulates the Activity of the Nox4/p22phox NADPH Oxidase
Nox4 (NADPH oxidase 4) is one of seven transmembrane NADPH oxidases that generate
reactive oxygen species (ROS): superoxide and H2O2 [212–215]. The generation of ROS by
the NOX enzymes occurs physiologically in response to various stimuli; these ROS act on signal
transduction pathways [212,213,216,217]. Nox4 is widely distributed in tissues, with the highest
levels in kidney [213]. Biochemical analysis of partially purified membrane free preparations of Nox4
revealed that Nox4 has a high Km for O2, and functions as an oxygen sensor, in that its activity responds
to the physiological pO2 [218]. These studies also demonstrated that the Nox4 reaction generates H2O2
as the primary product with a smaller amount of superoxide [218]. This response to pO2 has relevance
to the proposed role for Nox4 as an oxygen sensor that produces H2O2 as a signaling molecule [218].
Four of the Nox enzymes including Nox4 are associated with p22phox, which acts as a subunit that
interacts with regulatory proteins in response to cellular stimuli [212,219]. However, Nox4 binds
p22phox which is required for its activity, and is regarded as being constitutively active [213,215].
The role of PDIP38 in regulating Nox4 functions has been extensively studied in the cardiovascular
system [215,219]. PDIP38 was found to bind to p22phox and to activate the Nox4/p22phox enzyme
in vascular smooth muscle cells [220]. The latter study supports the view that PDIP38 is involved
in Nox4 localization, focal adhesion integrity, stress fiber formation, and plays a role in the maintenance
of vascular smooth muscle cell cytoskeletal functions. PDIP38 was found to co-localize with p22phox
at focal adhesions and stress fibers [220]. Overexpression of PDIP38 in vascular smooth muscle cells
increased NADPH oxidase activity several fold in a Nox4 dependent manner [220]. PDIP38 also
regulates vascular smooth muscle cell migration by regulating focal adhesion turnover and traction
force generation [221]. PDIP38 knockout in mice has shown that it is essential for development,
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as this led to perinatal lethality [222]. Analysis of aortas from heterozygous mice showed that these
exhibited abnormal structures and decreased contraction and compliance that are consistent with
a role in vascular function and integrity. Mouse embryonic fibroblasts derived from the knockout mice
exhibit defective growth characteristics, alterations in cell cycle progression and expression of cell
cycle proteins [223]. The subcellular localizations of Nox4/p22phox and PDIP38 in vascular smooth
muscle cells also raises questions regarding how these integrate into the fact that the Nox enzymes
are membrane associated proteins [212].
4.5. Summary
PDIP38 is unusual in that there is evidence for its role in a number of cellular functions, emanating
from the discovery of multiple protein partners. In addition to Pol δ and PCNA, PDIP38 interacts with
Pol η and other TLS pols. These findings together indicate a role for PDIP38 in regulating translesion
synthesis, while its association with Pol δ suggests it may be involved in the mechanisms or regulation
of the interchange between the TLS pols and Pol δ. In addition, PDIP38 is likely under regulation
from DNA damage signaling pathways and is translocated to the spliceosomes where it affects Mdm2
splicing and thereby p53 regulation.
Nevertheless, the studies of PDIP38 are still in their early stages, and its multifunctional nature
poses significant technical challenges to the use of gene depletion or knockouts either in cells or animals,
as these approaches may not allow unambiguous cause and effect relationships. Thus, much further
investigation is required to establish how these functions are accomplished at the molecular level,
as well as the cellular advantages of the investiture of these functions in a single protein. These require
biochemical approaches and, in particular, the elucidation of PDIP38 structure and its complexes
with its partners. These could lead to strategies for the use of targeted mutations that could provide
the means for isolating cause and effect in gene depletion experiments.
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